The focus of the Biostatistics Shared Resource (BSSR) is to collaborate with and provide support to Atrium Health Wake Forest Baptist Comprehensive Cancer Center (AHWFBCCC) members by providing analytical expertise and rigor that enhances peer-reviewed research to reduce the incidence of cancer, improve response and survival, reduce morbidity, manage symptoms, improve health-related quality of life and translate important laboratory discoveries into clinical practice.

The BSSR offers expert support in the statistical and analytical aspects of research studies. Our team collaborates with investigators on study design, sampling strategies, and data analysis planning, and provides guidance throughout the research lifecycle, including clinical trial monitoring, interim analyses, and final data interpretation. We ensure methodological rigor and deliver high-quality, reliable results to advance scientific discovery and support grant submissions and publications.

These core functions align with the BSSR's four primary goals:

  • Goal 1: Support investigator-initiated clinical protocol development, including developing appropriate statistical designs, preparing statistical sections and reviewing the statistical content of protocols submitted for review to the Protocol Review Committee of the AHWFBCCC.
  • Goal 2: Provide operational and analytical support for clinical protocols, including monitoring patient accrual, providing support for quality assurance efforts and performing interim and final analyses when needed.
  • Goal 3: Collaborate with the AHWFBCCC investigators from all programs to provide statistical design and data analysis in support of grant development, abstracts, presentations and publications.
  • Goal 4: Provide leadership, education and training in support of the AHWFBCCC mission, including participation in graduate-level courses, T32-supported training grants, mentoring teams for K awardees and other young investigators and leadership on committees responsible for scientific and administrative decisions for the Comprehensive Cancer Center, as well as conducting multiple seminar series on topics such as meta-analysis, survival analysis and early-phase adaptive designs for Comprehensive Cancer Center members.